Pacific Capital Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-19,250
Closed -$1.52M 58
2025
Q4
$1.52M Buy
19,250
+1,750
+10% +$139K 1.61% 22
2025
Q3
$1.44M Hold
17,500
1.6% 24
2025
Q2
$1.41M Sell
17,500
-20,000
-53% -$1.54M 1.32% 29
2025
Q1
$3.01M Buy
37,500
+2,500
+7% +$208K 1.9% 20
2024
Q4
$2.87M Hold
35,000
1.69% 19
2024
Q3
$2.89M Hold
35,000
1.69% 20
2024
Q2
$2.46M Sell
35,000
-10,000
-22% -$714K 1.63% 18
2024
Q1
$3.33M Buy
45,000
+5,000
+13% +$349K 2.18% 16
2023
Q4
$2.65M Sell
40,000
-17,500
-30% -$1.1M 1.99% 17
2023
Q3
$3.62M Buy
+57,500
New +$3.58M 2.19% 16

Other funds holding MET

Pacific Capital Partners's MET Position: Q1 2026 in Review

Pacific Capital Partners sold out of MetLife (MET) in Q1 2026, closing a stake of 19,250 shares — an estimated $1.52M sold.

Pacific Capital Partners first reported a position in MET in Q3 2023 and held it in 10 quarters. The position peaked at $3.62M in Q3 2023. 1,381 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Pacific Capital Partners reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Pacific Capital Partners sold 19,250 MetLife shares in Q1 2026, an estimated $1.52M.
  • Pacific Capital Partners first reported a position in MetLife in Q3 2023 and held it in 10 quarters.
  • Pacific Capital Partners's MetLife position peaked at $3.62M in Q3 2023.
  • 1,381 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Pacific Capital Partners's 13F filing for Q1 2026, filed 9 Apr 2026.